Clinical Trials Directory

Trials / Unknown

UnknownNCT04093284

Evaluation of Efficacy and Safety of Insulin Glargine Injected by Needle-free Jet Syringe

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Nanjing First Hospital, Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Using CGMS to compare the blood sugar improvement and patient sensibility of insulin glargine injected with needle-free jet injector and conventional insulin pen

Detailed description

Compared with conventional pen, needle-free jet injection of insulin has faster flow rate and larger area of local subcutaneous absorption. The aim of this study was to investigate the effects of subcutaneous insulin glargine injection with needle-free jet injection and conventional pen on blood glucose profile of CGMS and safety in type 2 diabetic patients.

Conditions

Interventions

TypeNameDescription
DEVICEThe needle-free jet injectorContinuous insulin therapy for 9 days

Timeline

Start date
2019-09-12
Primary completion
2019-10-20
Completion
2019-10-30
First posted
2019-09-18
Last updated
2019-09-18

Source: ClinicalTrials.gov record NCT04093284. Inclusion in this directory is not an endorsement.